Heart Disease News and Research

Latest Heart Disease News and Research

GIDAC recommends FDA approval of Janssen's REMICADE for treatment of pediatric UC

Janssen Biotech, Inc., formerly Centocor Ortho Biotech Inc., announced today that the Gastrointestinal Drugs Advisory Committee of the U.S. Food and Drug Administration recommended the approval of REMICADE for the treatment of moderately to severely active ulcerative colitis in pediatric patients who have had an inadequate response to conventional therapy.

22 Jul 2011

Leading cancer specialists and researchers establish Australia’s first comprehensive ‘Cancer Survivors Centre’

Australia’s first comprehensive treatment and research centre for the growing number of cancer survivors will be announced at the annual Ride for Life luncheon at NSW Parliament House today.

22 Jul 2011

BioMedix receives U.S. patent titled, 'System and Method for Testing for Cardiovascular Disease'

BioMedix, a leader in providing integrated Health Information Technology (HIT) products and services, has been awarded a U.S. Patent recognizing its innovative solutions and methods for detecting and managing cardiovascular disease.

22 Jul 2011

U.S. News recognizes HUMC among top 50 hospitals nationally in three specialties

Hackensack University Medical Center (HUMC) has been ranked among the top 50 hospitals nationally in three specialties – Cancer, Cardiology & Heart Surgery, and Geriatrics – in U.S. News Media & World Report's 2011-12 Best Hospitals rankings.

22 Jul 2011

Bristol-Myers Squibb signs definitive agreement to acquire Amira Pharmaceuticals

Bristol-Myers Squibb Company and Amira Pharmaceuticals, Inc., announced today that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire privately held Amira Pharmaceuticals, a small-molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory and fibrotic diseases.

22 Jul 2011

Viewpoints: Will Gang of Six compromise work?; endorsing birth control recommendations; Minn. budget deal

Not surprisingly, the plan has drawn complaints from the left about cuts to Social Security and Medicare, and from the right about defense cuts and tax increases. But the senators are right about the need to simplify and broaden the tax code and to put entitlements on a sustainable footing without slashing aid to the most vulnerable.

22 Jul 2011

Optimism could protect you from stroke: Study

The latest research from the University of Michigan shows that optimism reduces the risk of stroke. In a study of 6,044 adults over 50 with no history of stroke, optimism was associated with significantly reduced risk of stroke, even when controlling for stroke risk factors such as high blood pressure, heart disease and body mass index.

21 Jul 2011

High cost of multiple sclerosis drugs

According to a study released this Wednesday, drugs used in the hope of slowing multiple sclerosis progression may help some patients, but at a very high cost.

21 Jul 2011

Spacelabs Healthcare adds ICS Xprezz iPad application to Xprezzon monitoring line

Spacelabs Healthcare, a pioneer of patient monitoring and connectivity solutions, today announced the newest addition to the Xprezzon™ monitoring line - ICS Xprezz - a mobile application for the iPad. Building on Spacelabs' commitment to clinical partners, ICS Xprezz adds a new dimension in providing the best care experience for patients and their families.

21 Jul 2011

Galectin, University of Michigan enter collaboration to study role of Galectins in cardiovascular disease

Galectin Therapeutics Inc. today announced that it has entered into a research collaboration with Dr. Jose Jalife of the University of Michigan Medical School to better understand the relationship of Galectin-3 to cardiac fibrosis in chronic cardiac arrhythmias.

21 Jul 2011

Scientists find distinct links between smoking during pregnancy and long-term harm for the child

Scientists now understand more about why being exposed to nicotine while you were a fetus will increase your risk of developing cardiovascular disease as an adult. "We have found distinct links between cigarette smoking or even using nicotine patches or gum and the long-term harm for the child," says Dr. DaLiao Xiao, a scientist who works at the Loma Linda University School of Medicine in California.

21 Jul 2011

Neovasc to fund Tiara project with $4 million private placement

Neovasc Inc. today announced that it intends to complete a non-brokered private placement with accredited investors of up to four million equity units at the price of $1.00 per unit for aggregate gross proceeds of up to $4.0 million. The company expects that insiders will purchase approximately half of the units.

21 Jul 2011

Identification of third microRNA target triggers milestone payment from GSK to Regulus

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it has identified a third microRNA target in its alliance with GlaxoSmithKline (GSK), triggering a preclinical milestone payment from GSK.

21 Jul 2011

Isis commences ISIS-PTP1BRx Phase 1 study in type 2 diabetes

Isis Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 clinical study for ISIS-PTP1BRx, an antisense drug for the treatment of type 2 diabetes targeting protein tyrosine phosphatase-1B, PTP-1B.

21 Jul 2011

Baxter net income increases 15% to $615 million for second quarter 2011

Baxter International Inc. today announced strong financial results for the second quarter of 2011, and raised its financial outlook for full-year 2011.

From Baxter International Inc. 21 Jul 2011

World's best genetic map now built in African-Americans

A group of researchers from the University of Oxford, Harvard Medical School and the University of Mississippi Medical Center has constructed the world's most detailed genetic map, a tool scientists can use to better understand the roots of disease and how DNA is passed generationally to create diversity in the human species.

21 Jul 2011

Randox win Premier Healthcare Alliance contract for Quality Control

Randox Laboratories Ltd is proud to announce that in April 2011 we signed a multi-year agreement with the Premier Healthcare Alliance for the supply of Acusera Quality Control (QC) materials. The agreement will provide the 90,000 plus Premier members with access to our extensive range of quality control products and the benefits they offer clinical laboratories. When asked about the new agreement Laura Coyle Randox Business Manager for the USA revealed that ‘We look forward to strengthening our relationship with Premier and providing added value to their members’.

From Randox Laboratories Ltd. 21 Jul 2011

Obama backs 'Gang of Six' plan that includes Medicare cuts

The Senate's "Gang of Six" unveiled its 10-year, $3.7 trillion deficit reduction plan Tuesday and received a warm, bipartisan reception in the upper chamber. Meanwhile, in the House, GOP lawmakers, in a largely symbolic vote, passed their "cut, cap and balance" measure, which the White House has called "unacceptable."

21 Jul 2011

Diabetes trends in Alberta

The Alberta Diabetes Surveillance System was created in 2006 in partnership between Alberta Health and Wellness and the Institute of Health Economics. Led by Jeff Johnson in the University of Alberta's School of Public Health, the group has been identifying trends in diabetes, its associated health conditions and monitoring trends in accessing health-care services and has published a comprehensive report called a Diabetes Atlas every two years.

21 Jul 2011

Majority of people in the U.S., Europe express desire to seek early diagnosis of AD

Results of an international survey reveal that over 85% of respondents in the five countries surveyed say that if they were exhibiting confusion and memory loss, they would want to see a doctor to determine if the cause of the symptoms was Alzheimer's disease. Over 94% would want the same if a family member were exhibiting the symptoms.

21 Jul 2011

Heart Disease News and Research

Latest Heart Disease News and Research

GIDAC recommends FDA approval of Janssen's REMICADE for treatment of pediatric UC

Leading cancer specialists and researchers establish Australia’s first comprehensive ‘Cancer Survivors Centre’

BioMedix receives U.S. patent titled, 'System and Method for Testing for Cardiovascular Disease'

U.S. News recognizes HUMC among top 50 hospitals nationally in three specialties

Bristol-Myers Squibb signs definitive agreement to acquire Amira Pharmaceuticals

Viewpoints: Will Gang of Six compromise work?; endorsing birth control recommendations; Minn. budget deal

Optimism could protect you from stroke: Study

High cost of multiple sclerosis drugs

Spacelabs Healthcare adds ICS Xprezz iPad application to Xprezzon monitoring line

Galectin, University of Michigan enter collaboration to study role of Galectins in cardiovascular disease

Scientists find distinct links between smoking during pregnancy and long-term harm for the child

Neovasc to fund Tiara project with $4 million private placement

Identification of third microRNA target triggers milestone payment from GSK to Regulus

Isis commences ISIS-PTP1BRx Phase 1 study in type 2 diabetes

Baxter net income increases 15% to $615 million for second quarter 2011

World's best genetic map now built in African-Americans

Randox win Premier Healthcare Alliance contract for Quality Control

Obama backs 'Gang of Six' plan that includes Medicare cuts

Diabetes trends in Alberta

Majority of people in the U.S., Europe express desire to seek early diagnosis of AD

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Heart Disease News and Research

Latest Heart Disease News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in